SEC Form 4 · accession 0001144204-16-077669
INTERLEUKIN GENETICS INC · ILIU
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kenneth S Kornman
Officer — President and CSO · Director
Period of report
Jan 27, 2016
Accepted (ET)
Jan 28, 2016 · 5:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001037649
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1,F2 | $0.05 | Jan 27, 2016 | A | 400,000 | A | — | Jan 27, 2026 | Common Stock | 400,000 | 400,000 | D |
Explanation of responses
- F1The exercise price of the option is the closing price of the Issuer's common stock on the OTCQB on 1/27/2016, which was the grant date of the option.
- F2The option vests as to 25% of the shares on January 27, 2017, and 1/36th of the shares on the first day of each month beginning on February 1, 2017.